Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Goldstone

Showing results (271-280 of 311) with videos related to

Pageof 32
Sort By:
British Journal of Haematology|March 14, 2012
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trialJonathan I Sive, Georgina Buck, Adele Fielding, et al.
British Journal of Haematology|June 10, 2000
A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular responseJ M Foran, R K Gupta, D Cunningham, et al.
Blood|March 25, 2006
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993Hillard M Lazarus, Susan M Richards, Raj Chopra, et al.
Lancet (London, England)|June 7, 2005
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantationKarl S Peggs, Ann Hunter, Rajesh Chopra, et al.
British Journal of Haematology|March 1, 1997
Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: mobilization of Philadelphia-negative peripheral blood stem cellsE A Chalmers, I M Franklin, S M Kelsey, et al.
Blood|February 4, 2010
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphomaJonathan R Lambert, Jamshed B Bomanji, Karl S Peggs, et al.
Bone Marrow Transplantation|January 16, 2021
Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trialR Pettengell, R Uddin, A Boumendil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcomeLisa J Russell, Amir Enshaei, Lisa Jones, et al.
American Journal of Hematology|July 29, 2016
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXIIAnita J Kumar, Phyllis A Gimotty, Joel M Gelfand, et al.
Blood|August 18, 2005
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993Jacob M Rowe, Georgina Buck, Alan K Burnett, et al.
Pageof 32

Showing results (271-280 of 311) with videos related to

Sort By:
Pageof 32
British Journal of Haematology|March 14, 2012
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trialJonathan I Sive, Georgina Buck, Adele Fielding, et al.
British Journal of Haematology|June 10, 2000
A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular responseJ M Foran, R K Gupta, D Cunningham, et al.
Blood|March 25, 2006
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993Hillard M Lazarus, Susan M Richards, Raj Chopra, et al.
Lancet (London, England)|June 7, 2005
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantationKarl S Peggs, Ann Hunter, Rajesh Chopra, et al.
British Journal of Haematology|March 1, 1997
Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: mobilization of Philadelphia-negative peripheral blood stem cellsE A Chalmers, I M Franklin, S M Kelsey, et al.
Blood|February 4, 2010
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphomaJonathan R Lambert, Jamshed B Bomanji, Karl S Peggs, et al.
Bone Marrow Transplantation|January 16, 2021
Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trialR Pettengell, R Uddin, A Boumendil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcomeLisa J Russell, Amir Enshaei, Lisa Jones, et al.
American Journal of Hematology|July 29, 2016
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXIIAnita J Kumar, Phyllis A Gimotty, Joel M Gelfand, et al.
Blood|August 18, 2005
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993Jacob M Rowe, Georgina Buck, Alan K Burnett, et al.
Pageof 32